MediciNova Inc. (MNOV)
NASDAQ: MNOV
· Real-Time Price · USD
1.33
0.03 (2.31%)
At close: Aug 15, 2025, 3:58 PM
1.33
0.00%
After-hours: Aug 15, 2025, 06:40 PM EDT
MediciNova Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | -999.77M | 1B | n/a | n/a | n/a | n/a | n/a | n/a | 4.03B | 37.5K | n/a |
Cost of Revenue | n/a | 5.18K | n/a | n/a | 5.35K | 5.49K | 5.7K | 54.12K | 53.62K | 47.93K | 54.19K | 60.7K | 49.61K | 6.37K | n/a | 6.15K |
Gross Profit | n/a | n/a | n/a | -5.37K | -5.35K | -999.78M | 999.99M | -54.12K | -53.62K | -47.93K | -54.19K | -60.7K | -49.61K | 4.03B | 37.5K | -6.15K |
Operating Income | -3.2M | -3.18M | -3.31M | -3.05M | -3.14M | -2.49M | -1.15B | -3.3M | -2.96M | -3.23M | -3.9M | -4.09M | -3.41M | -2.1M | -3.6M | -4.31M |
Interest Income | 336.11K | 390.1K | 447.85K | 435.35K | 397.51K | 436.26K | 437.93K | 451.42K | 509.05K | 427.3K | 253.75K | 91.28K | 37.34K | 36.47K | 36.15K | 34.34K |
Pretax Income | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M | -723.11K | -2.87M | -2.92M | -3M | -3.65M | -4.03M | -3.39M | -2.08M | -3.58M | -4.28M |
Net Income | -2.86M | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M | -723.11K | -2.87M | -2.87M | -3M | -3.41M | -3.97M | -3.36M | -2.08M | -3.58M | -4.28M |
Selling & General & Admin | 1.36M | 1.28M | 1.45M | 1.4M | 1.35M | 839.33K | 1.35B | 1.56M | 1.49M | 1.22M | 1.44M | 1.52M | 1.3M | 325.82K | 1.55M | 1.78M |
Research & Development | 1.84M | 1.91M | 1.86M | 1.65M | 1.78M | 1.65M | 794.71M | 1.74M | 1.48M | 2.01M | 2.45M | 2.56M | 2.11M | 1.78M | 2.09M | 2.53M |
Other Expenses | n/a | n/a | n/a | n/a | -16.04K | -2.2K | -14.15K | -23.21K | -463.31K | -194.73K | -8.47K | -30.34K | -13.74K | -14.21K | -13.38K | -8.97K |
Operating Expenses | 3.2M | 3.18M | 3.31M | 3.05M | 3.13M | 2.49M | 2.15B | 3.3M | 2.96M | 3.23M | 3.9M | 4.09M | 3.41M | 2.1M | 3.64M | 4.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 63.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.2M | 3.18M | 3.31M | 3.05M | 3.14M | 2.49M | 2.15B | 3.3M | 2.96M | 3.23M | 3.9M | 4.09M | 3.41M | 2.1M | 3.64M | 4.31M |
Income Tax Expense | n/a | 5.54K | n/a | n/a | n/a | -433.22K | -1.15B | n/a | -45.74K | 2.82K | -245.28K | -60.94K | -23.59K | -33.9K | n/a | -34.34K |
Shares Outstanding (Basic) | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.04M | 48.99M | 48.99M | 48.8M |
Shares Outstanding (Diluted) | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M | 49.04M | 48.99M | 48.99M | 48.8M |
EPS (Basic) | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 | -0.04 | -0.01 | -0.06 | -0.06 | -0.06 | -0.07 | -0.08 | -0.07 | -0.04 | -0.07 | -0.09 |
EPS (Diluted) | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 | -0.04 | -0.01 | -0.06 | -0.06 | -0.06 | -0.07 | -0.08 | -0.07 | -0.04 | -0.07 | -0.09 |
EBITDA | -3.2M | -3.18M | -3.3M | -3.04M | -3.13M | -2.48M | -1.14M | -3.3M | -2.96M | -3.23M | -3.89M | -4.09M | -3.41M | -2.1M | -3.59M | -4.3M |
EBIT | -3.2M | -3.18M | -3.31M | -3.05M | -3.14M | -2.49M | -1.15M | -3.3M | -2.96M | -3.23M | -3.9M | -4.09M | -3.41M | -2.1M | -3.6M | -4.31M |
Depreciation & Amortization | 5.18K | 5.18K | 5.18K | 5.37K | 5.35K | 5.49K | 5.7K | 54.12K | 53.62K | 47.93K | 54.19K | 60.7K | 49.61K | 6.37K | 7.17K | 6.15K |